0001179110-20-008002.txt : 20200702
0001179110-20-008002.hdr.sgml : 20200702
20200702175746
ACCESSION NUMBER: 0001179110-20-008002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheena Jonathan
CENTRAL INDEX KEY: 0001646649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 201011245
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-30
0
0001604821
Natera, Inc.
NTRA
0001646649
Sheena Jonathan
C/O NATERA, INC., 201 INDUSTRIAL ROAD
SUITE 410
SAN CARLOS
CA
94070
1
1
0
0
Chief Technology Officer
Common Stock
2020-06-30
4
M
0
28784
9.59
A
277854
D
Common Stock
2020-06-30
4
M
0
63331
10.41
A
341185
D
Common Stock
2020-06-30
4
S
0
92115
49.4406
D
249070
D
Stock Option (right to buy)
9.59
2020-06-30
4
M
0
28784
0
D
2026-04-07
Common Stock
28784
40830
D
Stock Option (right to buy)
10.41
2020-06-30
4
M
0
63331
0
D
2027-06-08
Common Stock
63331
39068
D
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vested fully and became exercisable on April 1, 2020.
The option shares vest over four years. 25% of the option shares vest and become exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Tami Chen, attorney-in-fact
2020-07-02